Samrat Pharmachem Limited (BOM:530125)
India · Delayed Price · Currency is INR 234.10
-6.25 (-2.60%)
At close: Feb 12, 2026
Samrat Pharmachem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 15.69 | 71.12 | 21.63 | 166.31 | 171.85 | 53.33 |
Depreciation & Amortization | 6.74 | 6.53 | 6.46 | 6.42 | 5.94 | 4.93 |
Other Amortization | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 |
Loss (Gain) From Sale of Assets | 0.86 | 0.95 | -0.18 | - | 0.23 | 0.18 |
Loss (Gain) From Sale of Investments | 0.17 | -4.05 | -9.87 | -0.23 | -0.08 | - |
Provision & Write-off of Bad Debts | - | - | - | - | 0.23 | -0.01 |
Other Operating Activities | -0.1 | 16.24 | -22.23 | -25.7 | 54.35 | 9.48 |
Change in Accounts Receivable | 82.51 | 127.45 | -176.06 | -80.99 | -106.09 | -51.93 |
Change in Inventory | -17.37 | -173.28 | 118.51 | -201.12 | -10.16 | 73.68 |
Change in Accounts Payable | -6.2 | -91.07 | 157.88 | 84.89 | 57.33 | -54.29 |
Change in Other Net Operating Assets | 40.89 | -54.81 | -2.03 | -43.96 | 1.13 | 12.61 |
Operating Cash Flow | 123.23 | -100.91 | 94.12 | -94.37 | 174.74 | 47.98 |
Operating Cash Flow Growth | -35.34% | - | - | - | 264.22% | - |
Capital Expenditures | -16.01 | -5.07 | -6.67 | -14.59 | -12.76 | -27.29 |
Sale of Property, Plant & Equipment | -0.25 | - | 0.18 | 0.99 | 0.76 | - |
Investment in Securities | -80.57 | 1.33 | -0.62 | -18.45 | -0.02 | -13.5 |
Other Investing Activities | 3.44 | 3.69 | 3.05 | 2 | 1.38 | 11.55 |
Investing Cash Flow | -93.39 | -0.05 | -4.06 | -30.05 | -10.64 | -29.23 |
Short-Term Debt Issued | - | 14.6 | - | 111.4 | - | - |
Total Debt Issued | 18.12 | 14.6 | - | 111.4 | - | - |
Short-Term Debt Repaid | - | - | -102.05 | - | -12.74 | -3.03 |
Long-Term Debt Repaid | - | - | - | - | - | -3.12 |
Total Debt Repaid | - | - | -102.05 | - | -12.74 | -6.15 |
Net Debt Issued (Repaid) | 18.12 | 14.6 | -102.05 | 111.4 | -12.74 | -6.15 |
Common Dividends Paid | -3.09 | -3.09 | -3.09 | -3.09 | - | - |
Other Financing Activities | -10.11 | -6.74 | -6.87 | -12.32 | -6.75 | -12.75 |
Financing Cash Flow | 4.92 | 4.77 | -112.01 | 95.99 | -19.49 | -18.9 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | 34.76 | -96.19 | -21.95 | -28.43 | 144.62 | -0.16 |
Free Cash Flow | 107.22 | -105.99 | 87.45 | -108.96 | 161.98 | 20.69 |
Free Cash Flow Growth | -42.33% | - | - | - | 682.87% | - |
Free Cash Flow Margin | 3.70% | -3.71% | 3.10% | -3.51% | 7.30% | 1.16% |
Free Cash Flow Per Share | 34.69 | -34.30 | 28.30 | -35.27 | 52.42 | 6.70 |
Cash Interest Paid | 10.11 | 6.74 | 6.87 | 12.32 | 6.75 | 12.75 |
Cash Income Tax Paid | 21.09 | 14.52 | 29.66 | 95 | 15.34 | 22.54 |
Levered Free Cash Flow | 95.75 | -124.04 | 85.05 | -126.9 | 134.99 | 2.56 |
Unlevered Free Cash Flow | 100.9 | -121 | 88.51 | -121.09 | 137.27 | 8.42 |
Change in Working Capital | 99.84 | -191.72 | 98.31 | -241.18 | -57.79 | -19.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.